NXGN's current price/earnings ratio is 150.16, which is higher than 95.42% of US stocks with positive earnings.
With a year-over-year growth in debt of 276.18%, Nextgen Healthcare Inc's debt growth rate surpasses 94.2% of about US stocks.
Nextgen Healthcare Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -21.43%, greater than the shareholder yield of just 17.79% of stocks in our set.
If you're looking for stocks that are quantitatively similar to Nextgen Healthcare Inc, a group of peers worth examining would be AEHR, NTCT, CPSI, ICAD, and RDWR.
NextGen Healthcare (formerly Quality Systems) develops and markets computer-based practice management, electronic health records and revenue cycle management applications as well as connectivity products and services for medical and dental group practices and small hospitals. The company was founded in 1974 and is based in Irvine, California.
NXGN Price Forecast Based on DCF Valuation
DCF Fair Value Target:
The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Nextgen Healthcare Inc. To summarize, we found that Nextgen Healthcare Inc ranked in the 28th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 51%. The most interesting components of our discounted cash flow analysis for Nextgen Healthcare Inc ended up being:
The company's compound free cash flow growth rate over the past 5.76 years comes in at -0.05%; that's greater than only 18.29% of US stocks we're applying DCF forecasting to.
Nextgen Healthcare Inc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than merely 0% of US stocks with positive free cash flow.
Relative to other stocks in its sector (Technology), Nextgen Healthcare Inc has a reliance on debt greater than 71.06% of them.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
For other companies in the Technology that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as NXGN, try CVET, DOX, ORCL, LPTH, and MTCH.